Dr. Nowak is focused on elucidating the immunopathologic mechanisms of myasthenia gravis, an autoimmune disorder targeting the neuromuscular junction in patients resulting in weakness. He is working toward identifying new drug targets as well as exploring the effectiveness of B cell directed therapies (e.g., rituximab).
Specialized Terms: Myasthenia Gravis; Guillian-Barre Syndrome (GBS); CIDP; Immune Therapies, Neuropathy; Charcot Marie Tooth Disease; ALS.
https://medicine.yale.edu/neurology/divisions/neuromuscular/nmresearch.aspx
Amyotrophic Lateral Sclerosis; Charcot-Marie-Tooth Disease; Myasthenia Gravis; Neurology; Guillain-Barre Syndrome; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Conditions | Study Title |
---|---|
Diseases of the Nervous System | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis |
Diseases of the Nervous System | Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP |
Diseases of the Nervous System | Myasthenia Gravis Inebilizumab Trial (MINT) |
Diseases of the Musculoskeletal System | Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT) |
Diseases of the Nervous System | Immunologic Mechanisms in Neurological Diseases |